UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. (Blood, 2014)

(untitled) - Fielding, A; Rowe, J; Buck, G; Foroni, L; Gerrard, G; Litzow, MR; Lazarus, H; Luger, S; Marks, D; McMillan, A; Moorman, A; Patel, B; et al.